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Abstract	
Purpose	 of	 review:	 In	 this	 review,	 we	 provide	 a	 general	 overview	 of	 recent	 bioengineering	
breakthroughs	 and	 enabling	 tools	 that	 are	 transforming	 the	 field	 of	 regenerative	medicine.	We	
focus	on	 five	key	areas	 that	are	evolving	and	 increasingly	 interacting	 including	mechanobiology,	
biomaterials	 and	 scaffolds,	 intracellular	 delivery	 strategies,	 imaging	 techniques,	 and	
computational	and	mathematical	modelling.		
	
Recent	 findings:	Mechanobiology	plays	an	increasingly	important	role	in	tissue	regeneration	and	
design	of	therapies.	This	knowledge	is	aiding	the	design	of	more	precise	and	effective	biomaterials	
and	 scaffolds.	 Likewise,	 this	 enhanced	 precision	 is	 enabling	 ways	 to	 communicate	 with	 and	
stimulate	cells	down	to	their	genome.	Novel	imaging	technologies	are	permitting	visualization	and	
monitoring	of	all	these	events	with	increasing	resolution	from	the	research	stages	up	to	the	clinic.	
Finally,	algorithmic	mining	of	data	and	soft	matter	physics	and	engineering	are	creating	growing	
opportunities	to	predict	biological	scenarios,	device	performance,	and	therapeutic	outcomes	with			
	
Summary:	We	have	found	that	the	development	of	these	areas	is	not	only	leading	to	revolutionary	
technological	 advances	 but	 also	 enabling	 a	 conceptual	 leap	 focused	 on	 targeting	 regenerative	
strategies	 in	 a	 holistic	 manner.	 This	 approach	 is	 bringing	 us	 ever	more	 closer	 to	 the	 reality	 of	
personalized	and	precise	regenerative	medicine.		
	
	
Introduction	
The	increasing	integration	of	traditional	scientific	disciplines	such	as	materials	science,	chemistry,	
and	biology	and	the	emergence	of	research	fields	like	synthetic	biology,	supramolecular	chemistry,	
or	 mechanobiology	 continue	 to	 expand	 the	 field	 of	 bioengineering.	 Today,	 the	 field	 of	
bioengineering	 is	 a	 testament	 to	 the	 possibilities	 of	 interdisciplinary	 research.	 Regenerative	
medicine	 is	 a	 particularly	 interesting	 target	 for	 the	 development	 and	 application	 of	 novel	
bioengineering	 solutions.	 The	 inherent	 biological	 and	 molecular	 complexity,	 multi-scale	
organizations,	and	spatio-temporal	features	of	regenerative	processes	can	be	tackled	through	an	
ensemble	of	technological	angles.	For	example,	most	regenerative	challenges	can	now	be	tackled	
through	 a	 holistic	 understanding	 of	 biological	 events,	molecular	 design,	 selective	monitoring	 or	
sensing,	and	the	capacity	to	numerically	simulate	events	to	predict	or	optimize	performance.	This	
cooperative	 strategy	 is	 resulting	 in	 ever	 more	 integrated	 therapeutic	 approaches	 that	 are	
redefining	 the	 traditional	 view	 of	 implants,	 devices,	 drugs,	 or	 biomaterials.	 In	 this	 review,	 we	
attempt	 to	 provide	 a	 general	 overview	 of	 work	 being	 conducted	 in	 recent	 years	 in	 five	 key	
complementary	 areas	 of	 bioengineering	 including:	 mechanobiology,	 biomaterials	 and	 scaffolds,	
intracellular	delivery,	sensing	and	imaging,	and	computational	and	mathematical	modeling	(Figure	
1).	
	
	
Mechanobiology	in	regenerative	medicine	
In	 the	 body	 cells	 encounter	 a	 dynamic	 environment.	 To	 respond	 to	 chemical	 and/or	 physical	
stimuli,	 cells	 reorganize	 their	 cytoskeleton	and	alter	 their	 function.	 The	 current	paradigm	states	
that	cells	have	the	ability	to	constantly	probe	their	environment.	They	do	so	by	exerting	minute	
forces	 to	 sense	 the	 physical	 properties	 of	 their	 matrix.	 This	 process,	 known	 as	
mechanotransduction,	 takes	 place	 at	 the	 sites	 of	 cell	 adhesion	 and	 leads	 to	 the	 activation	 of	
signalling	cascades	to	control	cell	function.	Similarly,	the	lack	of	appropriate	physical	cues	leads	to	
altered	 cellular	 states,	 as	 observed	when	 isolated	 cells	 are	 cultured	 in	 vitro	 in	 plastic	 dishes.	 In	
these	 conditions,	 several	 cell	 types	 dedifferentiate,	 and	 stem	 cells	 lose	 their	 self-renew	 and	
progressively	enter	senescence.		
	
Matrix	 stiffness	 as	 relevant	 physical	 stimulus	 to	 control	 stem	 cell	 differentiation	 was	 first	
highlighted	by	Engler	et	al	[1].	Long	term	culture	of	stem	cells	on	matrices	with	stiffness	similar	to	
bone	 would	 upregulate	 genes	 and	 express	 protein	 characteristic	 of	 osteogenic	 differentiation.	
Similarly,	matrices	with	stiffness	of	muscle	or	brain	would	result	in	myogenesis	and	neurogenesis,	
respectively.	Such	cell	fate	decisions	require	the	modulation	of	myosin-II	contractility.	A	plethora	
of	 studies	 later	explored	 the	use	of	other	materials	 to	generate	matrices	with	 tunable	 stiffness,	
including	 extracellular	matrix	 (ECM)	 protein-based	 gels,	 polysaccharide-based	 alginate	 gels,	 and	
non-natural	 polymeric	 gels,	 such	 as	 polyacrylamide.	 Since	 the	 later	 are	 chemically	 inert,	 cell	
adhesion	 is	 enabled	 by	 coating	 matrices	 with	 ECM	 proteins.	 The	 validity	 of	 these	 results	 was	
questioned,	due	to	the	fact	that	the	modulation	of	gel	stiffness	is	obtained	by	changing	the	density	
of	crosslinkers,	which	in	turn	alters	surface	porosity,	geometry	and	ligand-binding	capabilities	[2].	
Nevertheless,	in	a	rebuttal	study,	Engler	and	coworkers	produced	two	families	of	polyacrylamide	
gels	 of	 constant	 stiffness	 (bone-like	 and	 fat-like	 stiffness),	 but	 with	 varying	 porosity	 or	 ligand-
substrate	tethering.	Since	differentiation	was	not	affected	by	changes	in	porosity	or	tethering,	the	
authors	concluded	that	stiffness	was	the	only	cue	directing	cell	fate	[3].	An	alternative	and	elegant	
solution	was	proposed	by	Fu	et	al.	using	micropost	arrays	of	 constant	material	 composition	but	
featuring	different	micropost	heights	 [4].	By	doing	so,	 the	authors	decoupled	substrate	stiffness	
from	 surface	 properties,	 and	 observed	 similar	 differentiation	 patterns	 to	 those	 found	 using	
synthetic	gels.	Studies	culturing	cells	 inside	3D	hydrogels	have	confirmed	 that	matrix	mechanics	
does	 also	 control	 cell	 fate	 in	 a	 cellular	 environment	more	 similar	 to	 tissue.	 Huebsch	et	 al.	 first	
reproduced	 in	3D	alginate	gels	the	results	previously	found	 in	2D	polyacrylamide	gels	 [5].	Again,	
when	 cultured	 within	 matrices	 whose	 stiffness	 mimicked	 bone	 or	 adipose	 tissue,	 stem	 cells	
secreted	 proteins	 typically	 associated	 with	 osteogenesis	 or	 adipogenesis,	 respectively.	
Nevertheless,	recent	findings	have	suggested	that	in	3D	conditions,	cell	fate	does	not	depend	on	
matrix	stiffness	but	rather	on	the	cell’s	ability	to	degrade	its	surrounding	matrix,	to	then	generate	
traction	forces	onto	it	[6].		
	
Within	tissue,	cells	are	normally	subjected	to	a	variety	of	dynamic	mechanical	forces,	such	as	fluid	
shear	 stress,	 tension	 and	 (hydrostatic)	 compression.	 While	 a	 large	 number	 of	 studies	 have	
examined	the	role	of	mechanical	forces	on	stem	cell	differentiation,	it	is	difficult	to	draw	general	
conclusions	due	to	the	multifactorial	nature	of	mechanical	stimuli.	Mechanical	loading	regimes	are	
defined	by	the	type	of	 load	(strain,	compression,	shear),	 the	magnitude,	dimensionality	(uniaxial	
or	biaxial),	loading	frequency	and	duration	of	the	overall	regime.	As	a	result,	no	systematic	study	
exists	 but	 rather	 a	 myriad	 of	 studies	 assessing	 the	 effect	 of	 a	 particular	 loading	 regime.	 To	
summarize	briefly	 the	main	 findings,	 cyclic	 strain	 induces	osteogenesis	 [7,	 8]	 or	 chondrogenesis	
[8],	fluid	shear	stress	favours	osteogenesis	[9]and	vasculogenesis	[9],	while	hydrostatic	pressure	or	
uniaxial	compression	favours	chondrogenesis	[10,	11].	
	
Modulation	 of	 cell	 spread	 area	 and	 shape	 using	 micropatterning	 is	 also	 considered	 within	 the	
repertoire	 of	methods	 to	 control	 stem	 cell	 fate	 by	physical	means.	 Smaller	 cell	 spread	 areas	 or	
round	patterns	are	associated	with	adipogenesis	[12]	or	maintenance	of	stemness	[13].	Larger	cell	
spread	areas	[14]	or	cell	shapes	with	concave	edges	[15,	12]	that	promote	actin	cable	formation	
promote	osteogenesis,	with	differentiation	being	associated	with	changes	 in	cytoskeletal	protein	
assembly	and	signalling	via	RhoA	and	Rock	 [16,	14].	Along	 these	 lines,	disruption	of	actomyosin	
stress	 fibers	 by	 chemical	means	 also	 leads	 to	 adipogenic	 or	 neurogenic	 differentiation	 [17-19].	
Together,	 these	 results	 highlight	 the	 role	of	 cytoskeletal	 tension	 as	 a	 key	 regulator	of	 stem	cell	
fate.	
	
The	mechanical	connection	between	the	cell	and	its	environment	is	not	restricted	to	the	physical	
link	between	ECM,	focal	adhesions	and	cytoskeleton.	Rather,	it	extends	deeper	into	the	cell	via	a	
group	of	proteins,	the	LINC	complex,	that	mechanically	connect	the	cytoskeleton	to	the	nucleus.	It	
has	been	suggested	that	this	physical	 link	may	serve	as	an	efficient	and	fast	relay	of	mechanical	
information	directly	to	the	nucleus	via	an	‘action	at	a	distance’	mechanism.	Nevertheless,	little	is	
still	known	about	the	actual	players	of	the	mechanotransduction	event	and	the	proteins	involved	
in	 converting	 the	physical	 signal	 into	a	 chemical	 signal.	 Candidate	proteins	 include	 the	YAP/TAZ	
pathway,	which	has	been	suggested	as	a	hub	 for	 the	conversion	of	mechanical	 information	 into	
chemical	 information.	 YAP/TAZ	 is	 broadly	 implicated	 in	 cell	 fate	 decisions,	 and	 studies	 using	
mechanical	 stimuli	 as	 diverse	 as	 modulation	 of	 cell	 spread	 area	 [20],	 matrix	 stiffness	 [21]	 or	
mechanical	loading		[22]	have	all	identified	YAP/TAZ		as	key	player.	Increased	cytoskeletal	tension	
is	 also	 associated	 with	 increases	 in	 laminA	 expression	 and	 its	 phosphorylation,	 resulting	 in	
translocation	 of	 retinoic	 acid	 receptor	 γ	 (RARG)	 to	 the	 nucleus	 [21]	 and	 the	 activation	 of	 the	
retinoic	acid	signalling	pathway.	Finally,	 increased	actin	polymerization	 levels	(or	specifically,	the	
decrease	 in	 G-actin	 levels)	 have	 also	 been	 shown	 to	 induce	 differentiation	 by	 upregulating	 the	
activity	of	MAL	and	its	binding	to	serum	response	factor	(SRF)	to	activate	its	transcription	[13].		
	
A	plethora	of	studies	report	similar	results	on	stem	cells	from	other	origins,	such	as	hematopoietic	
[23],	 adipose	 [24],epidermal	 [13],	 embryonic	 [25],	 and	 neural	 [26].	 Recent	 studies	 have	 further	
assessed	 the	 fate	and	 therapeutic	 capabilities	of	mechanically-conditioned	 cells	when	used	as	 a	
xenograft	 transplantation	 model	 [27].	 Still,	 it	 remains	 to	 be	 understood	 whether	 mechanical	
conditioning	is	most	efficiently	performed	ex	vivo	or	in	situ,	and	how	far	along	the	differentiation	
process	is	it	best	to	transplant	the	cells	into	its	target	location.		
	
There	 are	 still	 other	 avenues	 to	 explore	 concerning	 the	 physical	 properties	 of	 the	 cellular	
environment.	Synthetic	matrices	are	treated	as	purely	elastic	materials	than	can	be	fully	described	
with	a	 single	mechanical	parameter,	Young’s	modulus.	Recent	 studies	have	explored	 the	 role	of	
viscoelasticity	as	a	cue	for	differentiation	[28].	Similarly,	other	‘advanced’	mechanical	behaviours	
such	 as	 non-linear	 elasticity	 (the	 fact	 that	 a	 material	 may	 feel	 stiffer	 when	 pulled	 harder)	 or	
mechanical	 anisotropy	 are	 prevalent	 in	 native	 tissue	 and	 should	 be	 considered	 as	 plausible	
mechanical	 cues	 in	 situ.	 Secondly,	mechanical	 cues	have	been	mostly	 designed	as	 uniform,	 and	
even	 when	 mechanical	 loading	 is	 applied,	 a	 single	 loading	 regime	 is	 used	 throughout	 the	
experiment.		Future	studies	should	consider	the	possibility	to	dynamically	tune	the	physical	stimuli	
presented	to	cells	as	they	progress	down	their	differentiation	route.		
	
Current	methods	are	still	reliant	on	the	ex	vivo	expansion	in	plastic	vessels	of	the	isolated	stem	cell	
population.	Nevertheless,	evidence	suggests	the	concept	of	‘mechanical	memory’,	that	is,	the	fact	
that	stem	cells	grown	for	long	periods	of	time	in	a	particular	matrix	stiffness	(either	soft	or	stiff)	
undergo	 commitment	 and	 cannot	 be	 later	 re-directed	 to	 a	 different	 lineage	 [1].	 A	 similar	
mechanical	memory	has	been	observed	when	stem	cells	are	stimulated	with	mechanical	 loading	
regimes	 [29].	 This	 phenomenon	 should	 force	 us	 to	 re-examine	 all	 stages	 of	 stem	 cell-based	
therapies,	 from	 isolation,	 to	 expansion,	 pre-transplantation	 and	 delivery,	 questioning	 the	
suitability	of	the	mechanical	environment	experienced	by	stem	cells	in	each	of	these	steps.	
	
	
Biomaterials	and	scaffolds	for	regenerative	medicine	
The	increased	capacity	to	design	at	the	nanoscale	is	enabling	the	recreation	of	biological	materials	
and	opening	the	possibility	to	guide	biological	processes.	This	opportunity	is	especially	attractive	
in	RM	and	 is	being	approached	both	from	the	bottom-up	building	with	molecules	[30]	and	from	
the	 top-down	 using	 advanced	 fabrication	 techniques	 [31].	 Today’s	 biomaterials	 can	 be	
programmable,	 information-rich,	 reversible,	 molecularly-designed	 or	 tissue-derived,	 bioactive,	
biomimetic,	and/or	capable	of	exhibiting	multiple	functions.	In	this	section,	we	provide	a	taste	of	
pioneering	 work	 with	 special	 focus	 on	 biomaterials	 with	 enhanced	 precision	 and	 potential	
functionality	for	RM	applications.		
	
Bioactive	biomaterials	
A	major	 goal	 in	 RM	 is	 the	 capacity	 to	 stimulate	 biological	 responses	with	 temporal	 and	 spatial	
control	while	 exhibiting	 functional	 physical	 properties.	With	 this	 in	mind,	 Yu	et	 al.	 developed	 a	
polysiloxane	membrane	that	acts	as	a	“second	skin”	and	restores	skin	function	thanks	to	its	bulk	
elasticity,	 contractility,	 adhesion,	 and	 breathability	 (Figure	 2a)	 [32].	 Material	 coatings	 can	 also	
provide	 such	 tissue-compatibility.	 For	 example,	 thin	 flexible	 perfluorocarbon	 layers	 have	 been	
developed	to	prevent	thrombosis	and	formation	of	bacterial	layers	[33].	Functionality	may	also	be	
enhanced	 not	 only	 by	 the	 properties	 of	 individual	 materials,	 but	 on	 their	 synergistic	 effect.	 A	
strong	 and	 tough	 hydrogel,	 a	 major	 biomaterial	 challenge,	 has	 been	 developed	 using	 an	
interpenetrating	polymer	network	that	 interacts	at	 the	molecular	scale	to	combine	stiffness	and	
brittleness	with	softness	and	elasticity	[34].	Another	example	integrates	modified	tropoelastin	and	
graphene	oxide	to	create	a	hydrogel	with	both	enhanced	mechanical	properties	and	conductivity	
with	potential	use	in	muscle	regeneration	applications	[35].	Designing	at	the	molecular	scale,	using	
for	 example	 recombinant	 technologies,	 facilitates	 the	 integration	 of	mechanical	 properties	 and	
biomolecular	 signaling.	 For	 example,	 Tejeda-Montes	 et	 al.,	 developed	 an	 elastin-like	 polymer	
membrane	with	outstanding	mechanical	properties	[36]	and	the	capacity	to	enhance	osteoblastic	
phenotype	 and	mineralization	 in	 vitro	 [37]	 as	well	 as	 bone	 regeneration	 in	 vivo	 [38].	Molecular	
design	enables	a	wide	variety	of	biomolecular	signaling	relevant	to	tissue	regeneration	 including	
for	example	regulation	of	the	immune	system	[39],	presentation	of	bioactive	peptides	[40],	growth	
factor	mimetics	[41],	or	tuneable	degradation	[42].	
	
Biomimetic	biomaterials		
Tissue	 regeneration	 is	 characterized	by	an	orchestrated	 set	of	dynamic	processes	where	a	wide	
variety	 of	 cells	 and	 structural	 and	 signaling	 molecules	 interact	 in	 a	 3D	 space.	 In	 this	 scenario,	
recreation	of	 the	3D	space	 is	essential	and	a	number	of	excellent	 reviews	address	 this	goal	 [43,	
44].	Despite	tremendous	work	in	this	area,	poorly	defined	animal	derived	matrixes	have	been	the	
material	of	choice	of	many	when	trying	to	recreate	in	vivo	scenarios.	It	is	essential	to	recreate	the	
complexity	of	such	environments	but	with	reproducible	and	controllable	tools.	To	this	end,	Lutolf	
and	colleagues	have	pioneered	modular	synthetic	hydrogel	systems	with	tuneable	matrix	elasticity	
and	 signaling	 properties	 to	 study	 the	modulation	 of	 cells	 (Figure	 2b)	 [45].	 The	 past	 decade	 has	
seen	 a	 particular	 emphasis	 on	 the	 understanding	 of	matrix	 stiffness	 to	 direct	 cell	 behavior,	 an	
exciting	 parameter	 to	 engineer	 therapies	 for	 RM.	 Recent	 studies	 have	 demonstrated	 the	
importance	of	stress-stiffening	[46],	stress	relaxation	[47],	and	3D	spatial	confinement	[48]	of	gels	
in	guiding	cell	phenotype.	
	
Self-assembling	biomaterials	
The	 last	 two	 decades	 have	 seen	 a	 growing	 interest	 in	 the	 development	 of	 supramolecular	
materials	based	on	self-assembly	due	to	the	possibility	to	fabricate	biomaterials	that	are	modular	
and	 tuneable	 and	 can	 be	 systematically	modified	 to	 enable	 properties	 such	 as	 responsiveness,	
bioactivity	 and	 multifunctionality	 [49].	 Self-assembling	 systems	 based	 on	 peptides	 have	 been	
particularly	popular	and	a	large	variety	of	excellent	reviews	have	been	published	on	this	topic	[50,	
51].	 The	 main	 advantage	 of	 these	 systems	 is	 the	 possibility	 to	 use	 bioinspired	 molecules,	
selectively	 interact	with	 biological	 ones,	 and	 easily	 engineer	 systematic	modifications	 to	 create	
materials	 that	 stimulate	 biological	 processes,	 recreate	 complex	 bioactive	 molecules,	 or	 tune	
environmental	 conditions.	 For	 example,	 using	 Fmoc-peptides,	 Alakpa	et	 al.,	 developed	 a	 simple	
self-assembling	 system	 with	 tuneable	 stiffness	 capable	 of	 directing	 cell	 behavior	 on	 demand	
(Figure	 2c)	 [52].	 Others	 have	 used	 self-assembling	 nanofibres	 to	 selectively	 recruit	 and	 deliver	
growth	 factors	 (GFs)	 for	 bone	 regeneration	 [53],	 cells	 to	 treat	 ischemic	 cardiovascular	 diseases	
[54],	or	even	mimic	complex	molecules	such	as	growth	factors	[41]	or	glycosaminoglycans	[55].	
	
Future	self-assembling	systems	are	expected	to	provide	a	 technological	and	 functional	 leap	 that	
will	 take	 us	 beyond	 precise	 nanostructures	 and	 into	 dynamic	 materials	 exhibiting	 remarkable	
properties	such	as	self-healing	or	the	capacity	to	grow	and	adapt.	These	biomaterials	will	emerge	
from	 combinatorial	 approaches	 capable	 of	 optimizing	molecular	 interactions	 through	 a	 natural	
selection	 of	 peptides	 [56]	 or	 proteins	 [57]	 and	 utilize	 dynamic	 intermolecular	 processes.	 For	
example,	Inostroza-Brito	et	al.,	have	introduced	a	peptide-protein	supramolecular	system	capable	
of	 accessing	 non-equilibrium	 for	 substantial	 periods	 of	 time	 and	 enabling	 growth	 and	
morphogenesis	into	vascular-like	tubular	structures	without	the	use	of	molds	or	templates	(Figure	
2d)	[58].	
	
Biofabrication	
The	functionality	of	 these	materials	 for	 regenerative	medicine	will	also	depend	on	the	way	they	
are	 processed.	 In	 additive	 manufacturing,	 for	 example,	 a	 large	 variety	 of	 bioinks	 are	 being	
developed	 with	 the	 goal	 of	 enabling	 bioactivity	 and	 biocompatibility	 while	 fulfilling	 critical	
processing	requirements	[59].	Novel	biofabrication	techniques	are	also	enabling	the	development	
of	 complex	 hydrogel	 materials	 [60].	 For	 example,	 photopatterning	 techniques	 can	 be	 used	 to	
generate	 chemically	 anisotropic	 regions	 containing	 patterns	 of	 peptides	 [61]	 or	 proteins	 [62].	
Another	 versatile	 approach	 includes	 direct-writing	 fabrication,	 which	 has	 been	 used	 to	 pattern	
cellulose	 fibrils	 that	give	rise	 to	dynamically	 reconfigurable	hydrogels	 [63]	or	 to	print	a	hydrogel	
within	 a	 self-healing	 hydrogel	 to	 create	 anisotropic	 environments	 [64].	 The	 capacity	 to	 create	
patterns	within	3D	soft	matter	is	enabling	targeting	of	a	major	challenge	in	regenerative	medicine,	
namely	 the	 generation	 of	 vascularized	 scaffolds.	 Examples	 include	 the	 use	 of	 multiphoton	
micromachining	 to	 create	 cm-deep	 vascularizing	 patterns	 [65]	 or	 bioprinting	 of	 multiple	 inks	
including	cells,	polymers,	and	hydrogels	to	create	vascularized	tissue-like	structures	[66].	A	major	
functional	 breakthrough	 was	 recently	 reported	 by	 Kang	 et	 al.,	 demonstrating	 the	 possibility	 to	
print	 various	polymer	and	hydrogel-based	 inks	with	an	 integrated	 tissue-organ	printer	 (ITOP)	 to	
create	living	human-size	calvarial	bone,	cartilage,	and	skeletal	muscle	[67].	
	
All	 these	 advances	 pave	 the	 way	 for	 an	 exciting	 future	 in	 biomaterials	 design.	 However,	 it	 is	
important	to	keep	 in	mind	that,	while	sophisticated	materials	continue	to	emerge,	most	current	
regenerative	 therapies	 continue	 to	 rely	 heavily	 on	 traditional	 materials.	 The	 necessary	 leap	 to	
transform	these	and	other	high-level	technologies	 into	functional	therapies	will	require	cohesive	
strategies	that	can	stimulate	both	creativity	and	innovation	and	facilitate	academic	and	industrial	
collaboration.		
	
	
Intracellular	delivery	strategies	for	regenerative	medicine	
Delivery	 strategies	 in	 RM	 are	 based	 on	 the	 controlled	 administration	 of	molecular	 regulators	 -	
protein	morphogens	 (e.g.	GFs),	nucleic	acids	 (e.g.	cDNA,	mRNA,	miRNA)	or	small	molecules	 (e.g.	
retinoic	acid,	dexamethasone)	 -	 to	 specific	 cells	or	 tissues	 to	modulate	cell	 fate,	or	 improve	 the	
niche	properties,	and	ultimately	promote	tissue	regeneration.	While	some	molecules	exert	 their	
action	extracellularly	(e.g.	GFs)	by	interacting	with	cell-surface	receptors,	nucleic	acid	therapeutics	
require	 internalization	 to	 access	 intracellular	 targets.	 Physical	 methods	 have	 been	 used	 to	
promote	 intracellular	 delivery	 of	 cargos,	 including	microinjection,	 opto-	 or	 electroporation	 and	
cavitation	 [68].	However,	 these	methods	are	quite	 invasive	as	 they	cause	membrane	disruption,	
being	typically	used	in	in	vitro	and	ex	vivo	strategies.	Clinically,	less	invasive	and	safer	approaches	
are	necessary.	Carrier-based	delivery	 systems	are	 typically	 internalized	by	endocytosis	 and	 their	
physicochemical	properties	(size,	shape,	charge,	ligand	density)	can	be	engineered	to	enhance	the	
delivery	of	anabolic	and	catabolic	factors	into	cells	[69].	In	this	way,	genes	can	be	turned	on	or	off	
to	 promote	 expression	 or	 inhibition	 of	 a	 certain	 protein	 involved	 in	 tissue	 regeneration.	 In	 this	
section,	we	highlight	the	use	of	bioengineering	approaches	to	design	multifunctional	nanocarriers,	
through	multivalency	 [70],	 targeting	and	cell-penetrating	ability	 [71],	 stimuli-responsiveness	 [72,	
73],	 and	 their	 application	 to	 promote	 selective	 intracellular	 delivery	 for	 optimized	 therapeutic	
outcomes.	
	
Reprogramming	cells	in	vitro		
Cell	reprogramming	involves	the	delivery	of	specific	transcription	factors	to	activate	endogenous	
genes	 in	a	cell	resulting	 in	 its	conversion	 into	another	cell	type.	A	 landmark	 in	cell	reprograming	
was	reported	by	Yamanaka	et	al.	who	were	able	to	convert	mouse	embryonic	or	adult	fibroblasts	
into	 induced	pluripotent	stem	cells	 (iPSCs)	by	delivering	four	transcription	factors	 (Oct3/4,	Sox2,	
Klf4,	 c-Myc)	 [74].	 The	 transduced	 cells	 showed	 characteristics	 of	 pluripotency,	 indicating	 the	
possibility	to	generate	PSCs	from	somatic	cells	for	applications	in	RM.	Since	viruses	have	specific	
mechanisms	 to	 release	 genetic	 material	 inside	 cells,	 the	 transcription	 factors	 were	 delivered	
through	 retrovirus.	 Since	 the	 pioneering	 work	 of	 Yamanaka,	 similar	 approaches	 were	 used	 to	
manipulate	 cells	 in	 vitro	 and	 then	 transplant	 them	 in	 vivo	 for	 treating	 diseases.	 For	 example,	
Filareto	et	al.	derived	corrected	dystrophic	iPSCs	from	mice	tail-tip	fibroblasts	missing	dystrophin	
and	utrophin,	 proteins	 implicated	 in	muscle	homeostasis.	After	 generating	myogenic	progenitor	
cells	 from	 differentiation	 of	 corrected	 dystrophic	 iPSCs,	 they	 transplanted	 the	 cells	 into	 the	
muscles	of	mice	with	muscular	dystrophy	 [75].	 Immunofluorescence	of	muscle	 sections	 showed	
cell	engraftment	and	expression	of	utrophin.	This	cell-based	therapy	led	to	some	improvements	in	
muscle	 function,	 but	 more	 efficient	 vectors	 are	 required	 to	 deliver	 reprogramming	 and	
differentiation	factors	and	improve	regeneration	outcomes.		
	
Viral-mediated	 transduction	 has	 been	 widely	 used	 in	 cell	 reprogramming,	 but	 the	 potential	
cytotoxicity	 an	 immunogenicity	 of	 viruses	 [76]	 has	 led	 to	 the	 development	 of	 non-viral	 vectors	
(nanocarriers)	 to	 deliver	 cargos	 inside	 cells	 [77].	 Dexamethasone	 (Dex),	 a	 water-insoluble	
glucocorticosteroid,	 has	 been	 used	 as	 a	 supplement	 in	 osteogenic	 medium	 to	 induce	 the	
differentiation	 of	 mesenchymal	 stem	 cells	 (MSCs)	 into	 the	 osteoblastic	 lineage.	 After	 cell	
internalization,	 Dex	 binds	 to	 glucocorticoid	 receptors	 on	 the	 nuclei,	 resulting	 in	 their	 activation	
[78]	 and	 consequent	 expression	 of	 Runx2	 gene	 [79]	 encoding	 a	 protein	 that	 is	 essential	 for	
osteoblastic	differentiation.	Dendrimers	[80]	and	polymeric	micelles	[81]	were	used	to	entrap	this	
hydrophobic	molecule	and	allow	its	sustained	release	intracellularly	in	rMSCs.	However,	for	in	vivo	
delivery	 to	 specific	 cells	 and	 minimizing	 side	 effects	 in	 other	 tissues,	 targeting	 strategies	 are	
necessary.	Santos	et	al.	functionalized	dendrimers	with	peptides,	identified	by	phage	display	and	
with	 high	 affinity	 for	MSCs,	 to	 deliver	 pDNA	 to	 those	 cells	 in	 vitro	 [82].	 Using	 pDNA	 encoding	
enhanced	green	fluorescent	protein	(eGFP)	and	firefly	luciferase	(FLuc),	successful	transfection	of	
cells	was	observed	with	low	levels	of	cytotoxicity.	Although	transfection	efficiency	was	superior	in	
cells	 treated	 with	 peptide-functionalized	 dendrimers,	 cell	 selectivity	 was	 not	 demonstrated.	 A	
similar	 targeting	 strategy	was	 developed	 using	 liposomes	 and	 phage-derived	 peptides	 targeting		
rMSCs	 to	 deliver	 sleeping	 beauty	 transposon	 plasmid	 [83].	 To	 promote	 nuclear	 translocation,	
nuclear	 localization	 signal	 peptides	 were	 also	 incorporated	 in	 the	 nanocarrier	 system.	 The	
identified	peptide	was	shown	to	be	selective	for	rMSCs	and	 improve	transfection	efficiency.	The	
osteogenic	differentiation	of	transfected	MSCs	was	not	affected,	suggesting	that	gene	delivery	can	
be	 used	 to	 induce	 sustained	 gene	 expression	 in	 adult	 stem	 cells	 and	 enhance	 its	 therapeutic	
potential.		
	
Promoting	tissue	regeneration	in	vivo	
In	cell-based	therapies,	 improving	the	properties	of	 the	niche	where	cells	will	be	transplanted	 is	
essential	to	ensure	cell	engraftment.	For	example,	inducing	angiogenesis	locally	can	promote	skin	
wound	healing	and	myocardial	regeneration.	Different	approaches	have	been	exploited	to	induce	
angiogenesis,	 including	 delivery	 of	 angiogenic	 factors	 (e.g.,	 vascular	 endothelial	 GF	 -	 VEGF),	
transplantation	of	endothelial	cells	 (ECs)	or	gene-based	therapies,	but	 it	has	been	challenging	to	
achieve	a	stable	vasculature.	Hubbell	and	co-workers	designed	a	peptide-based	vector	(binding	to	
DNA,	 nucleus	 and	 fibrin)	 to	 deliver	 pDNA	 encoding	 the	 stabilized	 variant	 of	 hypoxia-inducible	
factor,	a	transcription	factor	involved	in	the	regulation	of	various	pro-angiogenic	factors	[84].	The	
ability	 of	 the	 peptide-pDNA	 complexes	 embedded	 in	 a	 fibrin	matrix	 to	 promote	wound	 healing	
was	 tested	 in	 a	 mouse	 model	 of	 full-thickness	 dermal	 wound.	 Histological	 analysis	 showed	
increased	number	of	 ECs	 in	wounds	 treated	with	peptide-pDNA	 system	and	VEGF-A165	 (positive	
control),	when	compared	with	wounds	treated	with	fibrin	alone	(negative	control),	 indicating	an	
enhanced	angiogenic	response.	More	mature	vessels	were	observed	in	the	wounds	treated	with	
peptide-pDNA	 system,	 as	 compared	 with	 controls,	 since	 smooth	 muscle	 cells	 were	 detected	
around	the	vessels.	These	results	suggests	the	application	of	gene	delivery	as	a	strategy	to	achieve	
more	controlled	(physiological)	angiogenesis	and	obtain	more	mature	vascular	structures,	but	the	
efficiency	of	this	gene	therapy	still	requires	to	be	confirmed	in	models	of	impaired	wound	healing	
(diabetic	mice).		
	
Reconstruction	of	large	bone	defects	continues	to	be	a	major	clinical	challenge,	even	when	using	
autologous	 bone	 grafts.	 To	 promote	 osteointegration	 of	 bone	 implants,	 a	 liposome	 carrier	was	
used	to	deliver	cDNA	for	bone	morphogenetic	protein	2	 (BMP-2)	 into	peri-implant	bone	defects	
[85].	 Immunocytochemistry	 analysis	 showed	 the	 presence	 of	 BMP-2	 in	 cells	 migrating	 into	 the	
defects,	 demonstrating	 the	 successful	 transfection	 of	 cells	 in	 vivo.	 Bone	 regeneration	 was	
significantly	enhanced	in	the	defects	treated	with	liposomes	carrying	BMP-2	gene,	but	not	all	the	
regions	 of	 the	 defect	 showed	 complete	 bone	 healing.	 It	 was	 postulated	 that	 this	 might	 have	
resulted	from	the	 insufficient	number	of	cells	mobilized	to	certain	regions	of	the	defect	and	not	
due	 to	 low	 transfection	efficiency.	This	 suggests	 the	need	 for	a	homing	strategy	 to	 recruit	 stem	
cells	 into	 the	defect	site	using	carriers	 functionalized	with	stem	cell-binding	peptides	derived	by	
phage	display	[86].		
	
Metabolic	 bone	 disorders,	 such	 as	 osteoporosis,	 are	 characterized	 by	 abnormal	 calcium	
metabolism	and/or	bone	 cell	 physiology,	 leading	 to	bone	 loss	 and	 skeletal	 failure.	Osteoporosis	
drugs	typically	inhibit	bone	resorption,	preventing	bone	loss,	but	they	also	slowdown	the	process	
of	bone	formation	(osteogenesis).	Using	cationic	 liposomes	functionalized	with	a	peptide	known	
to	bind	to	calcified	tissues	of	lower	crystallinity,	Zhang	and	co-workers	were	able	to	deliver	small	
interference	RNAs	(siRNAs)	specifically	to	bone-forming	surfaces	(lower	crystallinity)	 in	vivo	 [87].	
By	silencing	the	Plekho1	gene,	that	encodes	a	protein	known	to	be	a	negative	regulator	of	bone	
formation	 [88],	 they	were	 able	 to	 stimulate	 bone	 formation.	 This	 delivery	 strategy	was	 further	
upgraded	 by	 including	 a	 DNA	 aptamer	 specific	 to	 rat	 osteoblasts	 (CH6)	 on	 the	 surface	 of	 lipid	
nanoparticles	(LNPs,	Figure	3a)	[89].	The	aptamer-functionalized	LPNs	loaded	with	Plekho1	siRNA	
were	shown	to	be	internalized	by	osteoblasts	in	vitro	(Figure	3b).	In	vivo	studies	using	osteopenic	
rats	 (low	 bone	 mineral	 density)	 showed	 enhanced	 bone	 formation	 with	 improved	
microarchitecture	 when	 rats	 were	 treated	 with	 CH6-siRNA-LNPs	 (Figure	 3c)	 as	 compared	 with	
other	groups.	By	selectively	stimulating	bone	formation	without	promoting	bone	resorption,	this	
therapy	 holds	 promise	 to	 treat	 osteoporosis.	 However,	 further	 experiments	 are	 required	 to	
investigate	possible	off-target	effects	of	this	delivery	strategy	and	determine	the	duration	of	the	
silencing	effect.		
	
	
Imaging	techniques	for	regenerative	medicine	
Imaging	technologies	offer	a	number	of	new	opportunities	in	RM,	for	example,	in	the	assessment	
of	the	tissue	composition	of	organs,	in	transplanted	cells	monitoring	or	in	cell	therapy	evaluation.	
The	imaging	modalities	currently	being	used	in	stem	cell	therapies	and	research	can	be	classified	
according	 to	whether	 the	 targets	 are	 labeled	with	markers	 and	whether	 the	monitoring	 can	be	
achieved	in	vivo	[90-93,	86,	94].	In	this	section,	we	will	present	an	overview	of	the	state-of-the-art	
imaging	technologies	 in	stem	cell	 research	and	RM	with	the	emphasis	placed	on	 in	vivo	 imaging	
technologies	 that	 are	 currently	 being	 used	 or	 are	 likely	 to	 be	 adopted	 in	 clinical	 cell	 therapies	
(Figure	4).		
	
In	vivo	imaging	technologies	in	clinical	use	
Several	matured	clinical	imaging	technologies	have	good	potential	in	clinical	stem	cell	therapies.	i)	
magnetic	resonance	imaging	(MRI)	is	a	very	promising	clinical	imaging	method	[95-97]	(Figure	4a).	
The	majority	MRI	signals	are	generated	by	the	nuclear	polarization	on	hydrogen	atoms	introduced	
by	the	strong	magnetic	field.	This	effectively	shows	the	water	distributions.	MRI	is	very	safe	to	use	
and	 is	considered	as	the	most	robust	 imaging	technology	 in	clinical	settings.	MRI	can	be	applied	
with	 contrast	 agent	 injection	 or	without	 any	 exogenous	 labels,	 and	 has	 no	 depth	 limitation.	 ii)	
Positron	emission	tomography	 (PET)	 injects	a	positron-emitting	radioactive	 isotope	 incorporated	
in	 a	metabolically	 active	molecule	 such	 as	 fluorodeoxyglucose	 (FDG)	 [98-100].	 In	 the	 circulating	
blood,	 FDG	decays	 by	 emitting	 a	 positron,	which	meets	 an	 electron	 and	produces	 two	photons	
moving	 in	opposite	directions.	PET	has	a	very	high	sensitivity	and	has	no	 limits	 in	 imaging	depth	
and	 therefore	 can	 be	 used	 for	 tracing	 cell	 expressing	 reporter	 proteins,	 but	 requires	 ionizing	
radiation	with	associated	biohazardous	labels.	In	addition,	rapid	image	acquisition	(usually	within	
a	day)	is	needed	for	PET	due	to	the	short	lifetime	of	the	radioligands.	iii)	Single	photon	emission	
tomography	 (SPECT)	 is	 a	 tomography	 technology	 and	 uses	 gamma	 rays	 for	 image	 acquisitions	
[101,	102].	By	collecting	2D	images	using	a	gamma	camera,	3D	images	can	be	reconstructed	based	
on	 multiple	 2D	 scans.	 SPECT	 has	 very	 high	 sensitivity	 and	 the	 tissue	 penetration	 depth	 is	 not	
limited	but	the	spatial	resolution	is	relatively	low.	Similar	to	PET,	SPECT	needs	ionizing	radiations,	
which	may	 impose	 radiation	 risks.	The	main	 limitation	of	SPECT	 is	 that	 the	 short	 lifetime	of	 the	
SPECT	agent	makes	it	only	suitable	for	short-term	cell	tracing.	iv)	Computed	tomography	(CT)	sent	
X-ray	 beams	 (or	 proton	 beam	 and	 synchrotron	 X-rays)	 through	 an	 object	 and	 the	 beams	 are	
subsequently	attenuated	differently	by	various	structures	in	the	object	according	to	their	densities	
[103,	104].	The	object	2-D	slice	can	then	be	reconstructed	through	computer	processing.	Similar	to	
MRI,	CT	has	no	limitations	on	imaging	depth.	However,	the	use	of	ionizing	radiation	such	as	X-rays	
to	a	certain	extent	limits	the	application	in	RM.	v)	Ultrasound	imaging	uses	acoustic	waves	from	2-
13	MHz	to	acquire	real-time	images	[105-107]	(Figure	4c).	Despite	a	widely	used	clinical	 imaging	
technology	offering	rapid	imaging	solutions	in	clinical	environment,	the	application	of	ultrasound	
imaging	in	RM	is	limited,	due	to	its	low	image	resolution	and	depth.	
	
In	vivo	imaging	technologies	for	pre-clinical	research	
In	addition	to	the	clinical	imaging	technologies	above,	there	are	several	other	important	research	
and	pre-clinical	imaging	modalities	for	RM.	i)	Photoacoustic	imaging	(PAI)	is	realized	by	using	laser	
excited	ultrasound	waves	to	generate	3D	images	of	soft	tissues	[108-110].	As	a	hybrid	approach,	
PAI	 has	 the	 high	 contrast	 and	 good	 specificity	 offered	 by	 optical	methods	 and	 the	 high	 spatial	
resolution	 and	deeper	 penetration	depth	provided	by	 the	ultrasound	modality.	 In	RM	PAI,	 gold	
nanoparticles	 used	 to	 label	 stem	 cells,	 can	 be	 tuned	 to	 have	 strong	 plasmon	 resonance	 at	 the	
excitation	 wavelengths	 to	 enhance	 the	 photoacoustic	 signal.	 ii)	 Optical	 coherence	 tomography	
(OCT)	 uses	 low	 coherence	 light	 to	 acquire	 multiple	 2D	 images	 through	 interferometry	 to	
reconstruct	 3D	 images	 [111-113].	 Although	 in	 most	 applications	 OCT	 is	 used	 as	 a	 label-free	
imaging	 technology,	 for	 stem	cell	 research,	 the	application	of	OCT	 relies	on	exogenous	 contrast	
agents	such	as	magnetic	and	 iron	oxide	particles,	proteins,	dyes,	and	nano-materials	to	enhance	
the	detection	sensitivity	to	molecular	 level.	 iii)	Bioluminescence	imaging	(BLI)	utilizes	native	light	
emissions	 from	 several	 bioluminescent	 organisms,	 e.g.	 the	 substrate	 D-luciferin	 by	 the	 enzyme	
Fluc	 from	 the	North	 American	 Firefly	 [114-116]	 (Figure	 4d).	 BLI	 is	 a	 low-cost	 approach	 offering	
both	high	signal-to-noise	ration	and	sensitivity,	and	has	been	widely	used	in	small	animal	studies.	
The	applications	of	BLI	 include	tracking	hematopoietic	stem	cell	engraftment	and	assessing	stem	
cell	 types.	 However,	 the	 strong	 scattering	 and	 absorption	 of	 the	 tissue	 limits	 the	 penetration	
depth	of	BLI.	iii)	Fluorescence	imaging	uses	an	external	light	source	to	excite	fluorescence	emission	
from	 a	 range	 of	 fluorescent	 labels,	 such	 as	 green	 or	 red	 fluorescent	 proteins	 (GFP	 or	 RFP)	 and	
quantum	 dots	 (QD)	 [117-119].	 The	 fluorescence	 image	 can	 be	 acquired	 by	 collecting	 the	
fluorescence	 emissions	 from	 the	 fluorophores.	 Similar	 to	 BLI,	 the	 penetration	 depth	 of	
fluorescence	 imaging	 is	 limited	 as	 a	 result	 of	 the	 strong	 absorption	 and	 scattering	 of	 the	
fluorescent	light	by	the	mammalian	tissues.	
	
Challenges	and	opportunities	in	stem	cell	imaging	
For	 the	 in	 vivo	 imaging	 technologies	 reviewed	 above,	 to	 some	 extent,	 they	 are	 limited	 by	 a	
number	 of	 factors,	 such	 as	 the	 radiation	 hazard,	 the	 imaging	 depth	 limited	 by	 the	 tissue	
absorption	and	scattering,	and	reduced	cell	tracking	time.	These	limitations	result	in	low	sensitivity	
and	 specificity,	 and	 limited	 ability	 to	 monitor	 cell	 changes	 and	 therapy	 progresses	 over	 time.	
Multimodality	 imaging	 is	 one	 promising	 direction	 to	 address	 such	 challenges,	 which	 combines	
multiple	imaging	methods	to	achieve	an	improved	imaging	performance	[120].	For	example,	high-
sensitivity	and	low-resolution	methods	such	as	PET	can	be	used	together	with	MRI	to	improve	the	
image	 resolutions.	 For	 imaging	 modalities	 with	 a	 low	 penetration	 depth	 such	 as	 fluorescence	
imaging	and	PLI,	one	possible	solution	is	to	use	implantable	endoscopic	 imaging	probes	that	can	
send	down	excitation	light	sources	and	at	the	same	time	to	collect	fluorescence	emission	from	the	
fluorophores	[121-123].	Alternatively,	implantable	imaging	sensors	can	be	embedded	in	the	tissue	
or	organ	 to	collect	 real-time	 images	and	communicate	with	an	external	device	 through	wireless	
signals	 [124,	125].	 It	 is	 foreseeable	that	 in	vivo	 imaging	will	play	an	 important	role	 in	 future	RM	
and	 may	 be	 performed	 routinely	 in	 clinical	 stem	 cell	 therapies	 throughout	 the	 course	 of	
treatment.	
	
	
Computational	and	mathematical	modelling	in	regenerative	medicine	
The	 ability	 of	 mathematical	 and	 computational	 models	 to	 guide	 experimental	 discovery	 is	
increasingly	appreciated	in	the	field	of	RM,	where	the	term	“in	silico”	is	more	and	more	used	when	
discussing	the	future	of	this	promising	field	[126-128].	This	section	discusses	recent	opportunities	
that	 could	 make	 computational	 and	 mathematical	 modelling	 an	 important	 pillar	 of	 future	 RM	
research.	
	
It	is	worthwhile	to	first	emphasise	why	computational	and	mathematical	modelling	is	important	in	
the	 field	 of	 RM.	 Regenerating	 organs	 requires	 the	 ability	 to	 recreate	 a	 suitable	 physical	 and	
biochemical	 environment	 for	 the	 cells	 to	 grow.	 Elements	 of	 such	 environment	 include	 the	
mechanical	 and	 geometric	 properties	 of	 the	 growth	 substrate,	 the	 transport	 properties	
determining	 the	 rate	 at	which	 nutrients	 and	oxygen	 are	 supplied,	 and	waste	 removed,	 and	 the	
level	 of	 mechanical	 load	 and	 fluid	 shear	 [129,	 128,	 130].	 Without	 the	 framework	 provided	 by	
mathematical	models,	it	would	neither	be	possible	to	quantify	and	predict	these	properties	nor	to	
establish	 a	 link	 between	 macroscopic	 variables	 -	 which	 can	 be	 observed	 and	 controlled	 in	 an	
experiment	-	and	microscopic	variables	that	affect	cell	fate	directly.	
	
An	 example	 of	 this	 link	 is	 offered	 by	 the	 development	 of	 bioengineering	 scaffolds.	 While	 the	
ambient	 concentration	 of	 oxygen	 and	 nutrient	 can	 be	 easily	 controlled	 in	 experiment,	 and	 the	
average	flow	rate	permeating	through	the	scaffold	adjusted,	the	local	perfusion	and	shear	stress	
level	experienced	by	each	cell	will	depend	on	the	microscopic	geometry	of	the	scaffold,	as	well	as	
the	nutrient	utilisation	by	surrounding	cells	[128].	This	coupled	transport-mechanics	phenomenon	
is	impossible	to	disentangle	by	simple	mechanicistic	arguments.	However,	it	lends	itself	perfectly	
to	computer	 implementations	 (Figure	5a)	 [131].	Validated	simulations	can	offer	 insights,	and	be	
used	 to	 establish	 engineering	 correlations,	 by	 for	 example,	 providing	 the	 local	 transport	
environment	experienced	by	each	single	cell	as	a	function	of	flow	rate	and	ambient	concentration.		
	
Today,	 purely	 mechanical	 phenomena	 related	 to	 bioengineering	 scaffolds	 can	 be	 simulated	
accurately.	 The	 wide	 availability	 of	 software	 to	 convert	 CT	 scans	 into	 a	 computer	 mesh	 (e.g.	
Mimics),	 and	 to	 solve	 the	 relevant	 fluid	 and	 solid	 mechanics	 equations	 (e.g.	 Fluent,	 Abacus),	
renders	 the	 implementation	 of	 a	 simulation	 for	 optimising	 the	 scaffold’s	microstructure	 within	
reach	of	any	modern	bioengineering	 lab.	The	challenge	that	will	probably	occupy	computational	
scientists	 in	 the	 future	 is	 the	 development	 –	 and	 validation	 against	 experiments	 -	 of	 suitable	
models	for	cell	growth,	mobility	and	interaction	[132,	133,	130].			
	
Two	 opportunities	 have	 emerged	 recently	 which	 could	 spur	 innovation	 in	 the	 development	 of	
substrates	for	cell	growth	and	models	of	cell	behaviour.	One	is	the	growth	of	the	discipline	of	soft	
matter	physics	and	engineering.	Such	discipline,	which	is	uniquely	fitted	to	describe	the	fragile	and	
water-filled	structures	where	cells	thrive,	seeks	to	establish	the	physical	principles	governing	the	
behaviour	 of	 materials	 formed	 by	 soft	 macromolecular	 and	 colloidal	 elements,	 including	 the	
coupling	of	deformation	mechanics,	chemical	reactions,	 fluid	flow,	physico-chemical	effects	such	
as	 swelling,	 phase	 change,	 etc.	 Thanks	 to	 development	 in	 this	 exciting	 discipline,	 our	 ability	 to	
rationally	 design	 materials	 with	 micro/nanostructure	 that	 favours	 the	 growth	 of	 cells	 and	 the	
ability	to	characterise	the	behaviour	of	cells	has	increased	dramatically	[134].		
	
A	recent	example	where	soft	matter	has	produced	important	results	is	the	development	of	surface	
micro-patterning	 technique	 to	 promote	 cell	 colonisation.	 Lithographic	 techniques	 can	 produce	
geometric	 features	 with	 exquisite	 control	 over	 microstructural	 geometry.	 However,	 deploying	
these	 techniques	 to	 produce	 cheaply	 and	 on	 large	 scales	 surface	 micropatterns	 on	 practical	
scaffolds	is	a	major	challenge	(e.g.	lithographic	techniques	are	not	suitable	to	pattern	the	curved	
surfaces	present	in	the	interior	of	three-dimensional	scaffolds).	Fluidic	phenomena	and	capillarity	
could	offer	an	alternative	route	to	micro-patterning.	For	example,	the	capillary	forces	produced	by	
evaporating	liquid	films	can	produce	remarkably	regular	patterns	in	fibres	mats	(Figure	5b)	[135].	
The	 geometry	 of	 these	 patterns	 can	 be	 accurately	 predicted	 based	 on	 the	 theory	 of	 elasto-
capillary	 coalescence,	 which	 has	 been	 the	 subject	 of	 increasing	 interest	 by	 the	 soft	 matter	
community	 recently	 [136].	 Patterning	 through	 wrinkling	 (Figure	 5c-e)	 is	 another	 approach	 that	
heavily	relies	on	recent	applications	of	non-linear	mechanics	theories	to	soft	matter	systems	[137].	
Such	 theories	 enable	 to	 predict	 the	 wavelength	 of	 the	 wrinkles	 with	 extraordinary	 precision,	
enabling	 for	 instance	 to	 design	 the	 spacing	 and	 stiffness	 of	 protrusion	 where	 cells	 can	 anchor	
themselves.	 In	 addition	 to	 provide	 insights	 and	 predictions	 on	 how	 to	 make	 new	 materials,	
mathematical	 and	 computational	 modelling	 of	 soft	 matter	 provide	 ways	 to	 characterise	 the	
deformation	of	cells,	enabling	for	instance	to	quantify	the	ability	of	cells	to	produce	blebs	that	can	
aid	their	motility	[138-140]	or	cell-substrate	adhesion	phenomena	[141].	
	
A	 second	 opportunity	 is	 the	 realisation	 of	 the	 importance	 of	 algorithmic	 mining	 of	 data	 as	 a	
predictive	 engineering	 tool	 in	 various	 areas	 of	 bioengineering	 [142,	 143].	 Data	 analysis	 is	 not	 a	
new	 discipline.	What	 is	 new	 is	 the	 availability	 of	 inexpensive	 sensors	 (pressure,	 concentration,	
optical	 signals,	 etc.)	 that	 can	 be	 connected	 to	 equally	 inexpensive	 devices	 (e.g.	 smartphones,	
microfluidics	kits,	and	Arduino	boards)	to	interrogate	in	real	time	the	behaviour	of	cultured	cells,	
tissues,	organs.	For	example,	one	could	conceive	devices	in	which	algorithms	analyse	multi-point	
data	of	cell	motility	from	different	positions	in	a	cell	monolayer	and	relate	these	to	perfusion	data	
extracted	from	simulations.	The	advent	of	“lab-on-a-chip”	technologies	[144,	145]	makes	the	real-
time	 interrogation	 of	 the	 data	 from	 micro-devices	 containing	 cells,	 and	 the	 feedback	 of	 this	
information	 to	 control	 the	 device’s	 operating	 parameters	 two	 important	 elements	 that	 require	
modelling.	 We	 believe	 that	 the	 convergence	 of	 cheap	 and	 robust	 sensing	 and	 imaging	
technologies,	 big	 data	 techniques,	 and	 physics-based	 computations	 could	 bring	 a	 new	 level	 of	
understanding	 of	 the	 complexity	 inherent	 in	 regenerative	 medicine	 constructs,	 particularly	 in	
situations	 in	which	 purely	 deterministic	 approaches	 have	 failed	 to	 provide	 sufficiently	 accurate	
predictive	capabilities.	
	
	
Conclusion	
Novel	 bioengineering	 technologies	 are	 redefining	 how	 we	 view	 and	 tackle	 key	 challenges	 in	
regenerative	medicine.	We	 have	 provided	 a	 general	 overview	 of	 five	 dynamic	 and	 increasingly	
evolving	areas	that	are	shaping	the	next	generation	of	regenerative	medicine	therapies	aiming	to	
provide	 more	 selective	 cell-material	 interactions,	 higher	 precision,	 faster	 monitoring,	 more	
selective	 delivery,	 and	 more	 accurate	 predictions.	 Throughout	 these	 different	 areas,	 a	 general	
theme	is	the	continuous	push	to	improve	precision,	sensitivity,	and	selectivity;	which	are	bringing	
us	closer	to	the	development	of	personalized	regenerative	medicine.		
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Figure	captions	
	
Figure	1	Summary	of	the	focus	of	this	review	highlighting	five	key	areas	that	are	coming	together	
to	transform	the	field	of	regenerative	medicine.	
	
Figure	 2	 (a)	 Comparative	 image	of	 the	polysiloxane	membrane	 serving	 as	 a	 “second	 skin”	 (XPL)	
capable	 of	 restoring	 natural	 function	 [33].	 (b)	 Organoid	 structures	 generated	 using	 a	 modular	
synthetic	 hydrogel	 with	 tuneable	 matrix	 elasticity	 and	 signaling	 properties	 [45].	 (c)	 Hydrogels	
exhibiting	 tuneable	 stiffness	 based	 on	 self-assembling	 Fmoc-peptides	 [52].	 (d)	 Dynamic	 self-
assembly	system	to	grow	tubular	vascular-like	scaffolds	(yellow	arrows	indicate	the	movement	of	
a	new	anastomotic	branch	grown	out	of	a	main	tubular	structure,	red	box	indicates	a	zoom	view	
of	mADSCs	growing	outside	of	the	tubular	structure	after	7	days	of	incubation)	[58].	
	
Figure	 3	 Stimulation	 of	 bone	 regeneration	 through	 targeted	 carrier-mediated	 delivery	 of	 genes	
silencing	inhibitors	of	osteogenesis:	(a)	Schematic	illustrating	the	preparation	of	lipid	nanoparticles	
(LNPs),	 small	 interference	 RNAs	 (siRNA)	 loading	 and	 insertion	 of	 CH6	 aptamer	 specific	 to	 rat	
osteoblasts;	(b)	Confocal	fluorescence	(first,	second	and	third	panels),	bright-field	(fourth	panel)	
and	merged	(fifth	panel)	microscopy	images	of	primary	rat	osteoblasts	showing	internalization	of	
CH6-siRNA-LNPs;	siRNA	is	stained	in	red,	endocytic	markers	(transferrin,	choleratoxin,	dextran)	in	
green	and	nuclei	in	blue;	(scale	bar	=	25	µm);	(c)	In	vivo	microcomputed	tomography	images	of	the	
proximal	 tibia	 of	 osteopenic	 ovariectomized	 (OVX)	 rats	 showing	 the	 3D	microstructure	 of	 bone	
before	and	after	administration	of	different	siRNA	formulations	(scale	bar	=	1	mm)	[89].	
	
Figure	 4	 Examples	 of	 imaging	 modalities	 for	 regenerative	 medicine	 and	 stem	 cell	 therapy:	 a)	
Representative	MR	 images	 for	mice	 receiving	 hMSc	 at	 Day	 0	 and	 Day	 16.	 F-MRI	 quantification	
correlates	very	well	with	the	number	of	 implanted	cells	at	Day	0	and	shows	detectable	hMSc	at	
Day	 16	 [146].	 (b)	 3D	 Longitudinal	 in	 vivo	 images	 by	 combined	 ultrasound	 and	 Photoacoustic	
imaging	 (PAI)	method	 of	 Au	 nanotracer-labeled	mesenchymal	 stem	 cells	 [105].	 Examples	 of	 BLI	
images	can	be	seen	in	[147].	The	arrow	shows	the	closeness	of	these	imaging	modalities	to	clinical	
stem	cell	treatment.	
	
Figure	 5	 (a)	Modelling	based	on	computational	 fluid	dynamics	 simulation	of	a	 scaffold	 for	bone	
regeneration	 [131];	 (b)	 Scaffold	 for	 mesenchymal	 stem	 cells	 formed	 by	 elasto-capillary	
coalescence	of	carbon	nanotube	fibres	(arrow	heads:	collapsed	and	laid	CNTs,	arrows:	CNTs	that	
were	shrunk	to	form	the	razor-sharp	peaks)	[135].	(c,	d)	surface	patterning	through	thin	soft	layer	
wrinkling	[137].	(e)	Finite	element	simulation	of	a	buckled	cylindrical	shell	[148].	
	
	
